{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:187",
      "entity_text" : "acetylcholine",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00641",
      "entity_text" : "3,4-DAP",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The beta2-adrenergic receptor agonists salbutamol and ephedrine have been found to be beneficial for CMS forms (such as CMS type 10) caused by DOK7 mutations that affect the maturation and maintenance of NMJ structure, whereas 3,4-DAP enhances acetylcholine release from the presynaptic nerve terminal.",
  "reading_complete" : "2020-08-08T09:48:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T09:45:51Z",
  "trigger" : "enhances",
  "evidence" : [ "3,4-DAP enhances acetylcholine" ],
  "pmc_id" : "4678414",
  "score" : 0
}